The 10-Point Plan 2021: Updated Concepts for Improved Procedural Safety During Facial Filler Treatments
Clin Cosmet Investig Dermatol. 2021 Jul 6;14:779-814. doi: 10.2147/CCID.S315711. eCollection 2021.ABSTRACTDermal filler treatments require constant reassessment for improving and safeguarding the rapidly evolving aesthetic field. Suboptimal injection technique, patient selection and product knowledge have touted a concerning increase in filler complications, with new challenges such as the COVID-19 pandemic leading to new paradigms in the understanding, prevention, diagnosis and treatment of complications. The updated 10-point plan has been developed to curtail complications through consideration of causative factors, categorized as patient, product, and procedure-related. Patient-related factors include a preprocedural consultation with careful elucidation of skin conditions (acne, rosacea, dermatitis), systemic disease (allergies, autoimmune disease, underlying bacterial and viral disease (herpes simplex virus, COVID-19 infection), medications (antineoplastic drugs, recreational drugs) and previous cosmetic procedures (including fillers and energy-based devices). Patient assessment should include standardized photography and also evaluate the role of social media, ethnicity, gender, generational, and LGBTQ+ needs. Specified informed consent for both adverse events and their treatment is essential due to the increase in vascular complications, including the risk of blindness. Product-related factors include the powerful advantage of reversibility when using hyaluronic acid (...
Source: Clinical, Cosmetic and Investigational Dermatology - Category: Dermatology Authors: Izolda Heydenrych Koenraad De Boulle Krishan Mohan Kapoor Dario Bertossi Source Type: research
More News: Acne | Allergy | Allergy & Immunology | Anatomy | Autoimmune Disease | Blindness | Cold Sores | COVID-19 | Dermatitis | Dermatology | Herpes | Opthalmology | Pandemics | Rosacea | Skin